Severe Maternal Morbidity Reported in ~3 Percent of Pregnancies

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

MONDAY, March 16, 2026 -- Severe maternal morbidity (SMM) affects almost 3 percent of pregnancies in Ontario between conception and six weeks postpartum, according a study published online March 16 in CMAJ, the journal of the Canadian Medical Association.

Maya Rajasingham, M.P.H., from McMaster University in Hamilton, Ontario, Canada, and colleagues characterized the frequency of SMM from conception to six weeks postpartum in a population-based cohort study of births at 20 or more weeks of gestation using administrative data in Ontario for 2012 to 2021. The frequency of SMM was assessed overall, by period of occurrence, and by SMM type.

The researchers found that the rate of SMM was 27.24 per 1,000 births among 1,095,228 births; 15.63, 55.02, and 29.34 percent of cases occurred antepartum, intrapartum, and postpartum, respectively. Severe hemorrhage overall was the most common SMM type (6.10 per 1,000 births), followed by acute abdomen antepartum (1.94), severe hemorrhage intrapartum (5.28), and sepsis postpartum (4.69). Across periods, there was variation seen in the characteristics associated with SMM; for example, a U-shaped relationship was seen for the frequency of intrapartum and postpartum SMM with maternal age, while antepartum SMM was associated with ages 15 to 19 versus 25 to 34 years (odds ratio, 2.22) but not ages 40 to 49 years.

"Severe maternal complications aren't just a delivery room issue -- they occur across pregnancy and after birth, and many first appear in emergency departments rather than obstetric units," senior author Giulia Muraca, M.P.H., Ph.D., also from McMaster University, said in a statement. "Improving maternal safety requires a whole-system approach, involving emergency care, primary care, maternity care teams, and postpartum follow-up."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-17 01:56

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords